Abstract: The present invention relates to effective diagnosis of patients and assisting clinicians in treatment planning. In particular, invention provides a medical analysis system that enables refinement of molecular classification. The system provides a molecular profiling solution that will allow improved diagnosis, prognosis, response prediction to provide the right chemotherapy, and follow-up to monitor for cancer recurrence.

Abstract: The present invention relates to effective diagnosis of patients and assisting clinicians in treatment planning. In particular, invention provides a medical analysis system that enables refinement of molecular classification. The system provides a molecular profiling solution that will allow improved diagnosis, prognosis, response prediction to provide the right chemotherapy, and follow-up to monitor for cancer recurrence.

Abstract: The present invention relates to effective diagnosis of patients and assisting clinicians in treatment planning. In particular, invention provides a medical analysis system that enables refinement of molecular classification. The system provides a molecular profiling solution that will allow improved diagnosis, prognosis, response prediction to provide the right chemotherapy, and follow-up to monitor for cancer recurrence.

Abstract: An apparatus that identifies an object includes a frequency detector (112) that detects a frequency over which an RFID tag (102) communicates, and an object identifier (120) that identifies the object based at least in part upon the detected frequency. The frequency detector may detect a plurality of frequencies over which a plurality of RFID tags transmit information. The apparatus also optionally includes a frequency pattern generator that generates a frequency pattern that is indicative of an identity of the object, wherein the object identifier compares the generated frequency pattern with known frequency patterns to determine the identity of the object.

Abstract: A wireless system includes a plurality of objects. The wireless system includes a controller and a radio frequency identification (RFID) read-write device. Each of the objects includes an RFID device and a transceiver. An object and methods of tracking objects are also disclosed.

Abstract: A wireless system includes a plurality of objects. The wireless system includes a controller and a radio frequency identification (RFID) read-write device. Each of the objects includes an RFID device and a transceiver. An object and methods of tracking objects are also disclosed.

Abstract: A wireless system (101) includes a plurality of objects (106). The wireless system includes a controller 102 and a radio frequency identification (RFID) read-write (RW) device (103, 104, 105). Each of the objects includes an RFED device (107) and a transceiver (108). An object and methods of tracking objects are also disclosed.

Abstract: Described herein is a patient monitoring system that includes a body network (16) with at least one sensor (12) that senses physiological information about a patient and a cognitive device (2) for communicating the physiological information to a remote location. The cognitive device includes a cognitive radio (4), a cognitive monitor (10), and a transmitter (8). The cognitive radio (4) checks detected frequency spectra (6) for unused bandwidth and recommends one or more bands on which to transmit clinically relevant information received from the body network (16) to the remote location; the cognitive monitor (10) receives the information from the body network (16), prioritizes the information based at least in part on a set of rules (30), and selects which information to transmit based on the prioritization and the recommended transmission bands; and the transmitter (8) transmits the selected information as a junction of priority over at least one or the recommended transmission bands.

Abstract: This invention relates to a method and an apparatus for determining a reliability indicator for at least one set of signatures obtained from clinical data collected from a group of samples. The signatures are obtained by detecting characteristics in the clinical data from the group of sample sand each of the signatures generate a first set of stratification values that stratify the group of samples. At least one additional and parallel stratification source to the signatures obtained from group of sample sis provided, the at least one additional and parallel stratification source to the signatures being independent from the signatures and generates a second set of stratification values. A comparison is done for each respective sample, where the first stratification values are compared with a true reference stratification values, and where the second stratification values are compared with the true reference stratification values.

Abstract: System and method for providing a customized service in a network. The system comprises at least one originating device that provides an identifier of one of a user and a product associated with the user (Tag ID) and an identifier of the customized service (Object ID). It further includes a processor that supports an action table. The processor receives the Tag ID and Object ID from the at least one originating device, and uses at least the received Tag ID and Object ID to look up a corresponding action in the action table. A servicing node in the system receives the action and performs at least partial execution of the action, thereby generating results comprising the customized service.

Abstract: A system and method are provided for performing a simulation of patient treatment using at least one executable clinical guideline. The method includes the steps of: providing for getting a selected start point associated with a step of a guideline, wherein the start point is selectable regardless of the actual treatment provided to the patient and condition of the patient; providing for accessing a guideline associated with the start point; and providing for performing a simulation. The simulation includes the steps of providing for processing the start point; providing for accessing the guideline having the step associated with the start point; and providing for executing at least the associated guideline including beginning execution at the start point.

Abstract: This invention relates to a method and an apparatus for determining a reliability indicator for at least one set of signatures obtained from clinical data collected from a group of samples. The signatures are obtained by detecting characteristics in the clinical data from the group of sample sand each of the signatures generate a first set of stratification values that stratify the group of samples. At least one additional and parallel stratification source to the signatures obtained from group of sample sis provided, the at least one additional and parallel stratification source to the signatures being independent from the signatures and generates a second set of stratification values. A comparison is done for each respective sample, where the first stratification values are compared with a true reference stratification values, and where the second stratification values are compared with the true reference stratification values.

Abstract: An apparatus that identifies an object includes a frequency detector (112) that detects a frequency over which an RFID tag (102) communicates, and an object identifier (120) that identifies the object based at least in part upon the detected frequency. The frequency detector may detect a plurality of frequencies over which a plurality of RFID tags transmit information. The apparatus also optionally includes a frequency pattern generator that generates a frequency pattern that is indicative of an identity of the object, wherein the object identifier compares the generated frequency pattern with known frequency patterns to determine the identity of the object.

Abstract: The present invention relates to effective diagnosis of patients and assisting clinicians in treatment planning. In particular, invention provides a medical analysis system that enables refinement of molecular classification. The system provides a molecular profiling solution that will allow improved diagnosis, prognosis, response prediction to provide the right chemotherapy, and follow-up to monitor for cancer recurrence.

Abstract: A system, a method and a computer-readable medium are provided for associating a nucleic acid profile or proteomic profile with a patient state, to utilize a healthcare protocol or guideline for decision support, in which the patient state provides a description of a current status and a history of a patient, and the nucleic acid profile or proteomic profile is an analysis of characteristics including genetic constitution, gene expression, or modification of the protein content of the tissue or cell, all of which aid in diagnosis of the disease state of a patient. The nucleic acid profile or proteomic profile shows a molecular indicator of the patient state. The invention also provides a method for associating a stage in the healthcare protocol or guideline with the nucleic acid profile or proteomic profile.

Abstract: The invention relates to a molecular diagnostic decision support system (MD-DSS) for providing patient related information (PRI). A patient information database (EMJ), a data input section (DAT) with molecular diagnostic input data (MDx) about the patient, a clinical guideline database (CL), a knowledge database (KB) are part of the system. A middleware section allows input data (MDx) to be processed into patient related information (PRI) by a first (1DSM) and a second (2DSM) decision support mechanism using the patient information database (EMJ), the clinical guideline database (CL) and the knowledge database (KB). The first (1DSM) and the second (2DSM) decision support mechanism are operably coupled through the middleware (MW) so as to interact (10, 11) during the processing of the input data (MDx). Due to this coupling of the two decision support mechanisms patient data are more efficiently combined with input data (MDx), and a more comprehensive approach with respect to the patient is obtained.

Abstract: A wireless system (101) includes a plurality of objects (106). The wireless system includes a controller 102 and a radio frequency identification (RFID) read-write (RW) device (103, 104, 105). Each of the objects includes an RFED device (107) and a transceiver (108). An object and methods of tracking objects are also disclosed.

Abstract: A device (DEV) which is capable of communicating using different spectrum opportunities comprises a communication unit (CMM) capable of communicating with other devices (DEV) and/or with communication networks, wherein the communication unit (CMM) is capable of communicating using different spectrum opportunities, and wherein a spectrum opportunity is defined by a set of at least one spectrum opportunity parameter; a label reader (REU; REU) capable of reading information (inf) from a label (TAG), wherein the information identifies at least one spectrum opportunity parameter of a spectrum opportunity; and switching means capable of switching the communication unit (CMM) to communicate using the spectrum opportunity as at least partially identified by the information (inf) read from the label (TAG).

Abstract: A system and method for transferring images among spectrum agile radio devices without the need to retransmit image data. The system and method of the invention encodes and transmits packets so as to permit the efficient recovery of image data that is lost during transmission without the need to retransmit the packets. Instead of encoding packets containing adjacent pixels and transmitting them line-by-line, the system and method of the present invention encodes and transmits packets containing pixels from non-adjacent areas of a frame. As a result, any losses that occur within an individual packet are distributed throughout the image rather than in a specific line or isolated region of the image. This permits the efficient recovery of image data that is lost during transmission without the need to retransmit the data.

Abstract: Variable and ambiguous factors in clinical guideline execution are further defined by prior expert medical scrutiny and testing. The definitions promote uniformity and ease of use, afford efficient interpretation by a medical device which can variably invoke the guideline (160) suited to the sensed current situation, and facilitate enterprise-wide administration of the rules under which a guideline for current operation is selected, preferably based on an ontology language (140). Guidelines are automatically deployed, and the deployment is managed. A patient care guideline formulated, medically approved and released includes logical structure (516) that has been specifically tailored to at least one value of at least one, but fewer than all, of a plurality of variables. Each of a set of clinical guidelines, including that guideline, is within a range of a function of the variables. A processor evaluates the function to select, from among the set, that guideline for current execution (S620).